DentaFilm Secures Tens of Millions in Pre-A Funding to Accelerate R&D and Ecosystem Expansion

VCBeat has learned that recently,Hefei Dentafilm Medical Equipment Co., Ltd. Announces Completion of Pre-A Financing Round Worth Tens of Millions of RMBThis round of financing was jointly invested by Haiheng Capital, Hongbo Capital, Chuanggu Capital, and the Hefei Angel Investment Fund.Following the completion of this funding round, Dentafilm will continue to intensify its R&D efforts in innovative, high-end intelligent dental medical equipment, expand mass production capabilities, accelerate product iteration, and broaden its ecosystem.

Hefei Dentafilm Medical Equipment Co., Ltd., as a pioneer of the smart oral healthcare ecosystem in China, centers on digital dental imaging technology. It specializes in the development of intelligent dental equipment and a full-industry-chain digital cloud platform, striving to become China’s leading provider of intelligent dental equipment and Full-Industry-Chain Platforms (FICP).

Dentafilm is the first enterprise in Anhui Province to obtain priority registration rights for multiple products (surgical microscopes, CR, and intelligent periodontal probes), filling a gap in related fields within the province and across China to some extent.Since its establishment, Dentafilm has received numerous honors, including recognition as a National High-Tech Enterprise, a Hefei Big Data Enterprise, and a Key Enterprise in Hefei’s Biopharmaceutical Industry. In 2020, it was selected for the first batch of provincial support projects for biopharmaceutical and high-end medical device industrial bases, and in November 2021, it was included in the “China Hidden Unicorn 500” list.In December 2021, Dentafilm invested RMB 4.5 billion to establish China’s first new-type dental medical industrial park.In April 2022, Dentafilm jointly established the High-End Medical Equipment Research Center and a Joint Graduate Training Base with Hefei University of Technology, a key national university under the Double First-Class Initiative.In the same month, strategic partnerships were established with multiple banks to integrate the financial services ecosystem.

As a builder of the full-chain ecological platform for oral care, Dentafilm has always adhered to the principle of "decentralization,"Leveraging DenteCloud as the central neural hub and the Feelin system as the connecting link, through systematic solutionsCreated a digital dental ecosystem platform that connects doctors, patients, and devices with seamless information interoperability and closed-loop business processes.

In 2022, Dentafilm launched the “Film Home · Smart Dentistry China” themed campaign, showcasing from multiple perspectives its accumulated expertise in digital dental transformation technologies over the years, and bringingDentafilm’s Cutting-Edge Insights and Solutions for the New Digital Dentistry Landscape. While sharing its innovative model for the oral ecosystem, Dentafilm also aims to bring its digital terminal products and integrated oral care solutions to the entire country, helping more clients achieve digital transformation.

According to relevant investors participating in this financing round: “Hefei Dentafilm Medical Equipment Co., Ltd. has demonstrated development performance in recent years that inspires strong confidence.”The company has consistently focused on R&D investment in intelligent dental devices. By leveraging digital dentistry application models, it has utilized technology to resolve the issue of data silos prevalent in traditional dental equipment, thereby establishing a novel Internet of Everything (IoE) clinical diagnosis and treatment scenario."This aligns perfectly with our vision for the terminal layout of digital dental medical equipment. We are also highly optimistic about Dentafilm’s innovative business model. Leveraging its dual strengths in R&D and marketing, the company has demonstrated clear leadership over competitors in product development, ecosystem deployment, and market share growth. We have every reason to anticipate Dentafilm’s rapid future growth and further consolidation of its competitive advantages in specialized segments of the dental industry."

Haiheng Capital (Hefei Haiheng Capital Management Co., Ltd.) is a state-owned sole proprietorship under the national-level Hefei Economic and Technological Development Zone, affiliated with the State-owned Assets Supervision and Administration Commission of the Development Zone. Established on September 1, 2020, the company has a registered capital of RMB 200 million. Adhering to the principle of “government guidance and market-oriented operation,” the company enhances the professional and market-oriented management of state-owned capital, serving as the manager of the Development Zone’s state-owned guidance funds, a market-oriented investment and operation entity, and a platform for the integration and operation of financial capital.

Hongbo Capital was established in May 2020. It is a private equity fund manager founded through collaboration between a professional management team and state-owned financial institutions, specializing in equity investment management. Adhering to the mission of serving the real economy through financial services, the company is committed to building an integrated investment framework of “investment + investment banking + resource integration” by leveraging comprehensive fund instruments. Embracing a long-term investment philosophy centered on value discovery, value creation, and value realization, Hongbo Capital provides systematic empowerment and value-added services—from capital to resources—to its portfolio companies, fostering mutual growth with enterprises while creating value for investors.

Chuanggu Capital, established in January 2018, is a market-oriented equity investment fund management company under Anhui Provincial Investment Group. Focusing on key industries such as big health, TMT, intelligent equipment, and new materials, Chuanggu Capital has built a full-lifecycle fund cluster spanning angel investing, venture capital (VC), private equity (PE), and mergers and acquisitions (M&A). To date, it manages 21 funds with assets under management exceeding RMB 8.7 billion. In the big health sector, its investment portfolio includes Bloomage Biotech, Yifan Pharmaceutical, Honghe Renai Medical, Zhongke Tuoran, Shangde Yaoyuan, Lianchuang Biology, Heyi Pharmaceutical, Qihao Medical, Inluo Medical, and Xingfu Gongchang, among others.

Hefei Angel Investment Fund was established in September 2014. Hefei Innovation Investment Co., Ltd., a subsidiary of Hefei Industrial Investment Holding Group, serves as the fund manager and initiated substantive operations of the fund management company in March 2017. Adhering to the strategic principle of “citywide coverage, deep cultivation in counties and districts, and expansion beyond Hefei,” it has actively built a “1+N” angel fund architecture cluster and has launched 13 county/district-level (including non-local) sub-funds. Currently, the total size of the Angel Fund stands at RMB 1.346 billion, with 258 projects approved cumulatively and a total approved investment amount of RMB 1.4025 billion. Among these, portfolio companies Kewell and Coretronic Microelectronics have been listed on the STAR Market; Hengshuo Semiconductor has passed the review meeting for the STAR Market; and Kechuang Zhongguang is undergoing filing and tutoring.

The Angel Fund has cumulatively introduced more than 800 high-level talents of various categories, with 41 enterprises receiving financial support for provincial high-level sci-tech talent team projects. Multiple enterprises have emerged prominently in provincial, municipal, and national competitions. The portfolio includes 100 national high-tech enterprises, 32 specialized and sophisticated (“Little Giant”) enterprises at the municipal level or above, 38 enterprises above designated size, and 8 enterprises valued at over RMB 1 billion. It has now become the largest direct-investment government angel fund in Anhui Province, ranking among the top in China.